Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 463

    1.

    Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax.

    Fowler RA, Sanders GD, Bravata DM, Nouri B, Gastwirth JM, Peterson D, Broker AG, Garber AM, Owens DK.

    Ann Intern Med. 2005 Apr 19;142(8):601-10.PMID: 15838066 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.

    Schmitt B, Dobrez D, Parada JP, Kyriacou DN, Golub RM, Sharma R, Bennett C.

    Arch Intern Med. 2007 Apr 9;167(7):655-62.PMID: 17420423 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. What is the most cost-effective way to protect people in the event of an anthrax terror attack?

    [No authors listed]

    Ann Intern Med. 2005 Apr 19;142(8):I40. No abstract available. PMID: 15838060 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Being prepared: modeling the response to an anthrax attack.

    Webb GF.

    Ann Intern Med. 2005 Apr 19;142(8):667-8. No abstract available. PMID: 15838074 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race.

    Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG.

    Ann Intern Med. 2003 Jun 17;138(12):960-8.PMID: 12809452 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

    Hutton DW, Tan D, So SK, Brandeau ML.

    Ann Intern Med. 2007 Oct 2;147(7):460-9.PMID: 17909207 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The cost-effectiveness of strategies to reduce mortality from an intentional release of aerosolized anthrax spores.

    Braithwaite RS, Fridsma D, Roberts MS.

    Med Decis Making. 2006 Mar-Apr;26(2):182-93.PMID: 16525172 [PubMed - indexed for MEDLINE]Related articles

    8.

    Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.

    Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM.

    Proc Natl Acad Sci U S A. 2006 May 16;103(20):7813-6. Epub 2006 May 3.PMID: 16672361 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis.

    Neuner JM, Hamel MB, Phillips RS, Bona K, Aronson MD.

    Ann Intern Med. 2003 Jul 15;139(2):113-22.PMID: 12859161 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

    Rothberg MB, Rose DN.

    Am J Med. 2005 Jan;118(1):68-77.PMID: 15639212 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

    Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, Plouffe JF, Cetron MS, Butler JC.

    JAMA. 1997 Oct 22-29;278(16):1333-9. Erratum in: JAMA 2000 Jan 19;283(3):341. PMID: 9343464 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    Hornberger J, Robertus K.

    Ann Intern Med. 2006 Sep 5;145(5):317-25.PMID: 16954357 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.

    Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK.

    Ann Intern Med. 2003 May 6;138(9):724-35.PMID: 12729427 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.

    Moore RD, Chaisson RE.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):15-21.PMID: 9377120 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vaccines and bioterrorism: smallpox and anthrax.

    Kimmel SR, Mahoney MC, Zimmerman RK.

    J Fam Pract. 2003 Jan;52(1 Suppl):S56-61. Review.PMID: 12556279 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pertussis in adolescents and adults: should we vaccinate?

    Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.

    Pediatrics. 2005 Jun;115(6):1675-84.PMID: 15930232 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.

    Rothberg MB, Bellantonio S, Rose DN.

    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9.PMID: 12965940 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

    Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

    Ann Intern Med. 2006 Dec 5;145(11):797-806.PMID: 17146064 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies.

    Bravata DM, Zaric GS, Holty JE, Brandeau ML, Wilhelm ER, McDonald KM, Owens DK.

    Biosecur Bioterror. 2006;4(3):244-62.PMID: 16999586 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data